Young, K., Hancock, G., Kregel, S., Bushnell, G. G., Nelson, E. R., McDonnell, D. P., & Fanning, S. W. (2025). Abstract C130: Identifying a novel therapeutic target, DKK1, in ESR1 mutant breast cancers. In Molecular Cancer Therapeutics (Vol. 24, pp. C130–C130). American Association for Cancer Research (AACR). https://doi.org/10.1158/1535-7163.targ-25-c130

Young, Kristen, Govinda Hancock, Steven Kregel, Grace G. Bushnell, Erik R. Nelson, Donald P. McDonnell, and Sean W. Fanning. “Abstract C130: Identifying a novel therapeutic target, DKK1, in ESR1 mutant breast cancers.” In Molecular Cancer Therapeutics, 24:C130–C130. American Association for Cancer Research (AACR), 2025. https://doi.org/10.1158/1535-7163.targ-25-c130.

Young K, Hancock G, Kregel S, Bushnell GG, Nelson ER, McDonnell DP, et al. Abstract C130: Identifying a novel therapeutic target, DKK1, in ESR1 mutant breast cancers. In: Molecular Cancer Therapeutics. American Association for Cancer Research (AACR); 2025. p. C130–C130.

Young, Kristen, et al. “Abstract C130: Identifying a novel therapeutic target, DKK1, in ESR1 mutant breast cancers.” Molecular Cancer Therapeutics, vol. 24, no. 10_Supplement, American Association for Cancer Research (AACR), 2025, pp. C130–C130. Crossref, doi:10.1158/1535-7163.targ-25-c130.

Young K, Hancock G, Kregel S, Bushnell GG, Nelson ER, McDonnell DP, Fanning SW. Abstract C130: Identifying a novel therapeutic target, DKK1, in ESR1 mutant breast cancers. Molecular Cancer Therapeutics. American Association for Cancer Research (AACR); 2025. p. C130–C130.